Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

FDA takes steps to allow critically needed supply of Janssen COVID-19 vaccine

Following careful review and deliberation, the U.S. Food and Drug Administration is taking important steps that will allow a critically needed supply of the Janssen (Johnson & Johnson) COVID-19 Vaccine to be made available.

11 Jun 2021

New 3D printing process helps build tailor-make artificial body parts, other medical devices

Using a new 3D printing process, University of Nottingham researchers have discovered how to tailor-make artificial body parts and other medical devices with built-in functionality that offers better shape and durability, while cutting the risk of bacterial infection at the same time.

11 Jun 2021

New framework establishes safe thresholds for antimicrobials

Researchers have made progress towards a G7 commitment to establish safe standards for the release of antimicrobials into the environment, by developing a new framework that establishes safe thresholds.

11 Jun 2021

Shark vNAR antibodies inhibit SARS-CoV-2 variants in vitro

Researchers in the UK and Austria have identified a novel class of antibodies that is highly effective at neutralizing the original strain of severe acute respiratory syndrome (SARS-CoV-2) and maintaining blocking activity against certain viral variants that have emerged.

10 Jun 2021

Zeus Industrial Products to integrate catheter-based contract manufacturer CathX Medical

Zeus Industrial Products, Inc., the global leader in advanced polymer solutions, announced today that it has finalized an agreement to integrate CathX Medical Inc. into its organization.

From Zeus Inc. 10 Jun 2021

New X-ray scanner could revolutionize cancer surgery, pathology, drug inspection

Engineers at Duke University have demonstrated a prototype X-ray scanning machine that reveals not just the shape of an object but its molecular composition. With unprecedented resolution and accuracy, the technology could revolutionize a wide range of fields such as cancer surgery, pathology, drug inspection and geology.

9 Jun 2021

Nose-to-brain: Nasal delivery of biopharmaceuticals to the brain

Placing medications as close as possible to the site of the disease: This sounds completely believable in theory, but is unfortunately not so simple in practice. While this works well for many drugs via the bloodstream or the digestive tract, it does not apply to the brain.

9 Jun 2021

Cold winter temperatures may accelerate spread of SARS-CoV-2

Writing in the journal Frontiers in Public Health, the team from Weifang Medical University said: “We believe that the low-temperature environment in winter may accelerate the spread of the outbreak and that new outbreaks may occur.”

9 Jun 2021

TSMC grant could boost TGen's efforts to track SARS-CoV-2 variants

The Translational Genomics Research Institute, an affiliate of City of Hope, today announced a substantial grant from Taiwan Semiconductor Manufacturing Co. Ltd., one of the world's largest manufacturers of computer chips, to help TGen sustain Arizona's fight against COVID-19.

8 Jun 2021

Chemical engineers devise a simpler process to incorporate hydrophobic drugs into tablets

About 60 percent of drugs on the market have hydrophobic molecules as their active ingredients. These drugs, which are not soluble in water, can be difficult to formulate into tablets because they need to be broken down into very small crystals in order to be absorbed by the human body.

8 Jun 2021

Novel COVID-19 vaccine is safe, generates immune response in healthy adults

The COVID-19 pandemic continues to disrupt and end lives around the world, and public health officials worldwide have recognized vaccines as the critical tools required for controlling the COVID-19 death toll and achieving a return to normal life.

8 Jun 2021

Researchers develop promising stem cell therapy to treat type 1 diabetes

Type 1 diabetes, which arises when the pancreas doesn't create enough insulin to control levels of glucose in the blood, is a disease that currently has no cure and is difficult for most patients to manage.

8 Jun 2021

Novel method allows rapid, absolute quantification of viral nucleic acids

Researchers from Critical Analytics for Manufacturing Personalized-Medicine, an Interdisciplinary Research Group at the Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, have developed a new method for rapid and accurate detection of viral nucleic acids - a breakthrough that can be easily adapted to detect different DNA/RNA targets in viruses like the coronavirus.

7 Jun 2021

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that it has completed enrollment and randomized the last patient in the global Phase 2/3 study with opaganib (Yeliva, ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840).

7 Jun 2021

The great promise of antiviral peptides against SARS-CoV-2

A new study, recently published in the journal Viruses, describes the impressive evidence for the role of antimicrobial peptidse (AMPs) in the treatment of COVID-19.

7 Jun 2021

Analysis of cells/colony motion offers new insight into the regenerative capacities of primary oral keratinocyte cultures

A comprehensive investigation on cells and colony motion offers new insight into the proliferative and epithelial regenerative capacities of human primary oral keratinocyte cultures with implications for quality control of engineered cells used in regenerative medicine.

7 Jun 2021

Suicide prevention efforts among a 'hidden population' living in public housing

New research suggests that African American families living in public housing are a "hidden population" when it comes to national suicide prevention efforts.

5 Jun 2021

FDA approves new treatment for patients with hypoplasminogenemia

Today, the U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tmvh) for the treatment of patients with plasminogen deficiency type 1, also referred to as hypoplasminogenemia, a disorder that can impair normal tissue and organ function and may lead to blindness.

5 Jun 2021

KHN’s ‘What the Health?’: The drug price dilemma

The high cost of prescription drugs is among consumers' top health policy issues, according to public opinion polls.

3 Jun 2021

How bacterial cells have been engineered to produce virus-resistant synthetic polymers

A recent Science paper discusses the utilization of a previously reported synthetic Escherichia coli to produce virus-resistant synthetic polymers.

3 Jun 2021

Manufacturing News and Research

Further Reading

FDA takes steps to allow critically needed supply of Janssen COVID-19 vaccine

New 3D printing process helps build tailor-make artificial body parts, other medical devices

New framework establishes safe thresholds for antimicrobials

Shark vNAR antibodies inhibit SARS-CoV-2 variants in vitro

Zeus Industrial Products to integrate catheter-based contract manufacturer CathX Medical

New X-ray scanner could revolutionize cancer surgery, pathology, drug inspection

Nose-to-brain: Nasal delivery of biopharmaceuticals to the brain

Cold winter temperatures may accelerate spread of SARS-CoV-2

TSMC grant could boost TGen's efforts to track SARS-CoV-2 variants

Chemical engineers devise a simpler process to incorporate hydrophobic drugs into tablets

Novel COVID-19 vaccine is safe, generates immune response in healthy adults

Researchers develop promising stem cell therapy to treat type 1 diabetes

Novel method allows rapid, absolute quantification of viral nucleic acids

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

The great promise of antiviral peptides against SARS-CoV-2

Analysis of cells/colony motion offers new insight into the regenerative capacities of primary oral keratinocyte cultures

Suicide prevention efforts among a 'hidden population' living in public housing

FDA approves new treatment for patients with hypoplasminogenemia

KHN’s ‘What the Health?’: The drug price dilemma

How bacterial cells have been engineered to produce virus-resistant synthetic polymers

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest Life Science News